CEBPZ and acute myeloid leukemia: Our study suggested that Baicalein showed HDAC‐1/8 inhibition effects and exerted outstanding anti‐leukemia effects in CBF‐AML, while no effects on the expression of HDAC inhibitor‐associated ABC transporter genes could be observed.